Aimovig 70 mg

Aimovig 70 mg is a subcutaneous solution used for migraine prevention. This medication, containing erenumab, is designed to help reduce the frequency of migraine attacks. Suitable for adults, it offers a convenient self-administered treatment option.

Aimovig 70 mg is primarily used for the prevention of migraines. It is a subcutaneous solution that contains erenumab, a medication that targets specific pathways involved in migraine attacks. People who experience frequent migraines may find this treatment helpful in reducing the number of migraine days they experience each month. Aimovig is not intended for the acute treatment of migraines but rather for long-term prevention.

Common effects of Aimovig 70 mg may include injection site reactions such as redness, pain, or swelling. Some individuals might experience constipation, muscle tightness, or fatigue. These effects are generally mild and temporary, but it's important to monitor any persistent or severe reactions and consult a healthcare provider if necessary.

Aimovig 70 mg should be stored at room temperature and protected from light. The solution should be clear and colorless; do not use if it appears discolored or contains particles. Always follow the instructions for subcutaneous administration provided by your healthcare provider. Keep the medication out of reach of children and pets.

Aimovig 70 mg may interact with other medications, particularly those that affect the immune system or blood pressure. It is important to inform your healthcare provider about all the medications you are taking, including over-the-counter drugs, vitamins, and herbal supplements. Alcohol consumption should be moderated, as it may exacerbate some side effects.